Unavailable
Unavailable
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/15/2025 | Market Perform | CJS Securities | |
| 7/26/2024 | $6.50 → $1.25 | Overweight → Equal-Weight | Morgan Stanley |
| 1/3/2024 | $8.00 | Underweight | Barclays |
| 12/20/2023 | $14.00 | Buy | Guggenheim |
| 9/27/2023 | $4.00 → $10.00 | Sell → Hold | Craig Hallum |
| 7/26/2023 | $5.00 → $13.00 | Equal-Weight → Overweight | Morgan Stanley |
| 4/11/2023 | $3.80 → $13.00 | Neutral → Buy | Goldman |
| 3/8/2023 | $4.00 | Hold → Sell | Craig Hallum |
10-K - WW INTERNATIONAL, INC. (0000105319) (Filer)
8-K - WW INTERNATIONAL, INC. (0000105319) (Filer)
8-K - WW INTERNATIONAL, INC. (0000105319) (Filer)
2025 Total Revenue and Adjusted EBITDA1,2 above high end of previously provided guidance Total End of Period Subscribers of 2.8 million; End of Period Clinical Subscribers of 130 thousand, up 42% year-over-year with continued growth in first quarter 2026 Fourth Quarter Total Revenue of $163 million; Clinical Subscription Revenue of $27 million, up 32% year-over-year Fourth Quarter Net Loss of $6 million; Net Loss Margin of 3.6%; Adjusted EBITDA1 of $18 million and Adjusted EBITDA Margin1 of 11.1% Provides First Quarter 2026 End of Period Subscriber Estimates and Full Year 2026 Financial Guidance NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weigh
Weight Watchers' Med+ members who regularly engaged with their GLP-1 Success Program lost up to 61% more body weight in the first month and 29% more in one year, on average, than those who took medication alone. Med+ members prescribed medication also reported, on average, over 30% more weight loss than select competitors at 12 months. NEW YORK, March 11, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers"), the global leader in science-backed weight health, today released a GLP-1 Results Report which finds that individuals who take GLP-1 medications and regularly engage in the Weight Watchers GLP-1 Success Program achieved significantly greater weight loss and
NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company") will release its results for the fourth quarter and full year 2025 ended December 31, 2025 before market open on Monday, March 16, 2026. Weight Watchers will host a conference call to discuss results at 8:30 a.m. ET the same day. The webcast of the conference call will be available on the Company's corporate website, corporate.ww.com, under Events and Presentations. A replay of the webcast will be available on this site for at least 90 days. About Weight WatchersWeight Watchers is the global leader in science-backed weight management, offering an integrated support system b
CJS Securities initiated coverage of WW with a rating of Market Perform
Morgan Stanley downgraded WW from Overweight to Equal-Weight and set a new price target of $1.25 from $6.50 previously
Barclays initiated coverage of WW with a rating of Underweight and set a new price target of $8.00
4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("WeightWatchers" or the "Company"), the global leader in science-backed weight management, today announced the launch of WeightWatchers for Menopause, a groundbreaking programme that sets a new standard in women's health, designed to support women through every stage of the menopause journey, from perimenopause to post-menopause. To launch the programme, WeightWatchers is partnering with Grammy and Emmy Award-winning and Oscar-nominated actress, producer, entrepreneur, and health advocate Queen Latifah as its first official spokeswoman. "Menopause has been a new journey for me—one that's changed how I see a
NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("WeightWatchers" or the "Company"), the global leader in science-backed weight management, today announced the launch of WeightWatchers for Menopause, a groundbreaking program that sets a new standard in women's health, designed to support women through every stage of the menopause journey, from perimenopause to post-menopause. To launch the program, WeightWatchers is partnering with Grammy and Emmy Award-winning and Oscar-nominated actress, producer, entrepreneur, and health advocate Queen Latifah as its first official spokeswoman "Menopause has been a new journey for me—one that's changed how I s
NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("WeightWatchers" or the "Company"), the global leader in science-backed weight management, today announced the appointment of Alejandro Bethlen as Executive Vice President, International, effective immediately. In this role, Bethlen will oversee WeightWatchers' business outside of the United States, driving international growth and innovation across the Company's global footprint. With more than two decades of experience scaling consumer, e-commerce, and marketplace businesses worldwide, Bethlen will play a pivotal role in strengthening WeightWatchers' leadership in weight health. "Alejandro's international e
2025 Total Revenue and Adjusted EBITDA1,2 above high end of previously provided guidance Total End of Period Subscribers of 2.8 million; End of Period Clinical Subscribers of 130 thousand, up 42% year-over-year with continued growth in first quarter 2026 Fourth Quarter Total Revenue of $163 million; Clinical Subscription Revenue of $27 million, up 32% year-over-year Fourth Quarter Net Loss of $6 million; Net Loss Margin of 3.6%; Adjusted EBITDA1 of $18 million and Adjusted EBITDA Margin1 of 11.1% Provides First Quarter 2026 End of Period Subscriber Estimates and Full Year 2026 Financial Guidance NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weigh
NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company") will release its results for the fourth quarter and full year 2025 ended December 31, 2025 before market open on Monday, March 16, 2026. Weight Watchers will host a conference call to discuss results at 8:30 a.m. ET the same day. The webcast of the conference call will be available on the Company's corporate website, corporate.ww.com, under Events and Presentations. A replay of the webcast will be available on this site for at least 90 days. About Weight WatchersWeight Watchers is the global leader in science-backed weight management, offering an integrated support system b
NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("WeightWatchers," "WW," or the "Company") will release its results for the third quarter 2025 ended September 30, 2025, before market open on Thursday, November 6, 2025. WeightWatchers will host a conference call to discuss results at 8:30 a.m. ET the same day. The webcast of the conference call will be available on the Company's corporate website, corporate.ww.com, under Events and Presentations. A replay of the webcast will be available on this site for at least 90 days. About WeightWatchersWeightWatchers is the global leader in science-backed weight management, offering an integrated support system that co
SC 13G/A - WW INTERNATIONAL, INC. (0000105319) (Subject)
SC 13G/A - WW INTERNATIONAL, INC. (0000105319) (Subject)
SC 13G - WW INTERNATIONAL, INC. (0000105319) (Subject)